Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Ruck

Showing results (81-90 of 235) with videos related to

Pageof 24
Sort By:
Ebiomedicine|August 3, 2019
Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort studyTobias Ruck, Andreas Schulte-Mecklenbeck, Steffen Pfeuffer, et al.
Journal of Neurology|June 13, 2024
Fatigue and associated factors in myasthenia gravis: a nationwide registry studyMattea Funke, Maria Eveslage, Jana Zschüntzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Ocrelizumab initiation in patients with MS: A multicenter observational studyErik Ellwardt, Leoni Rolfes, Julia Klein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 10, 2021
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine TreatmentLeoni Rolfes, Steffen Pfeuffer, Jana Hackert, et al.
Muscle & Nerve|November 4, 2018
Intubation, tracheostomy, and decannulation in patients with Guillain-Barré-syndrome-does dysphagia matter?Jens Burchard Schröder, Thomas Marian, Paul Muhle, et al.
Neuroradiology|January 8, 2025
The role of carotid elongation for intervention time and outcome in mechanical thrombectomy for anterior circulation acute ischemic strokeVivien Lorena Ivan, Christian Rubbert, Daniel Weiß, et al.
Neurological Research and Practice|December 29, 2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019Marc Pawlitzki, Laura Acar, Lars Masanneck, et al.
Multiple Sclerosis and Related Disorders|February 12, 2022
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumabSaskia Räuber, Marc Pawlitzki, Melanie Korsen, et al.
Neuro-Signals|October 18, 2017
Increase of Substance P Concentration in Saliva after Pharyngeal Electrical Stimulation in Severely Dysphagic Stroke Patients - an Indicator of Decannulation Success?Paul Muhle, Sonja Suntrup-Krueger, Stefan Bittner, et al.
Neurological Research and Practice|April 1, 2021
Consequences of COVID-19 pandemic lockdown on emergency and stroke care in a German tertiary stroke centerRobin Jansen, John-Ih Lee, Bernd Turowski, et al.
Pageof 24

Showing results (81-90 of 235) with videos related to

Sort By:
Pageof 24
Ebiomedicine|August 3, 2019
Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort studyTobias Ruck, Andreas Schulte-Mecklenbeck, Steffen Pfeuffer, et al.
Journal of Neurology|June 13, 2024
Fatigue and associated factors in myasthenia gravis: a nationwide registry studyMattea Funke, Maria Eveslage, Jana Zschüntzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 11, 2020
Ocrelizumab initiation in patients with MS: A multicenter observational studyErik Ellwardt, Leoni Rolfes, Julia Klein, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 10, 2021
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine TreatmentLeoni Rolfes, Steffen Pfeuffer, Jana Hackert, et al.
Muscle & Nerve|November 4, 2018
Intubation, tracheostomy, and decannulation in patients with Guillain-Barré-syndrome-does dysphagia matter?Jens Burchard Schröder, Thomas Marian, Paul Muhle, et al.
Neuroradiology|January 8, 2025
The role of carotid elongation for intervention time and outcome in mechanical thrombectomy for anterior circulation acute ischemic strokeVivien Lorena Ivan, Christian Rubbert, Daniel Weiß, et al.
Neurological Research and Practice|December 29, 2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019Marc Pawlitzki, Laura Acar, Lars Masanneck, et al.
Multiple Sclerosis and Related Disorders|February 12, 2022
A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumabSaskia Räuber, Marc Pawlitzki, Melanie Korsen, et al.
Neuro-Signals|October 18, 2017
Increase of Substance P Concentration in Saliva after Pharyngeal Electrical Stimulation in Severely Dysphagic Stroke Patients - an Indicator of Decannulation Success?Paul Muhle, Sonja Suntrup-Krueger, Stefan Bittner, et al.
Neurological Research and Practice|April 1, 2021
Consequences of COVID-19 pandemic lockdown on emergency and stroke care in a German tertiary stroke centerRobin Jansen, John-Ih Lee, Bernd Turowski, et al.
Pageof 24